Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 16/20 | 0.50 |
| ▸ | ITGA2B | P08514 | 12/20 | 0.50 |
| ▸ | ITGAV | P06756 | 5/20 | 0.48 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.43 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.43 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7091859 | 0.86 | GPR119 (0.48) | ITGB3ITGA2BITGAVITGB1ITGB5 | |
| SCHEMBL6677720 | 0.79 | ITGB3 (0.69) | ITGB3ITGA2BITGAVL3MBTL3L3MBTL1 | |
| SCHEMBL7037287 | 0.79 | ITGB3 (0.56) | ITGB3ITGA2BITGAVITGB1ITGB5 | |
| SCHEMBL7365797 | 0.78 | ITGB3 (0.72) | ITGB3ITGA2B | |
| SCHEMBL7365800 | 0.78 | ITGB3 (0.72) | ITGB3ITGA2B | |
| SCHEMBL11677942 | 0.73 | MTNR1A (0.60) | ITGB3ITGA2BITGAVITGB1ITGB5 | |
| SCHEMBL6643325 | 0.73 | ITGB3 (0.53) | ITGB3ITGA2BITGAVITGB1ITGB5 | |
| SCHEMBL6642395 | 0.73 | ITGB3 (0.53) | ITGB3ITGA2BITGAVITGB1ITGB5 | |
| SCHEMBL6646029 | 0.73 | ITGB3 (0.53) | ITGB3ITGA2BITGAVITGB1ITGB5 | |
| SCHEMBL13801428 | 0.71 | SIGMAR1 (0.72) | L3MBTL3L3MBTL1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3960482-B2 | — | — | 2007-08-15 | — | — | JP | claimed |
| EP-0910563-B1 | INTEGRIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-05-02 | — | — | EP | claimed |
| US-6008213-A | A INHIBITOR OF VITRONECTIN RECEPTOR AND FIBRINOGEN RECEPTOR; USEFUL FOR INHIBITING PLATELET AGGREGATION AND OSTEOPOROSIS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-12-28 | — | — | US | claimed |
| EP-0910563-A1 | INTEGRIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-04-28 | — | — | EP | claimed |
| EP-0910563-A4 | — | — | 1999-04-28 | — | — | EP | claimed |
| WO-1997001540-A1 | INTEGRIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-01-16 | — | — | WO | claimed |
| EP-0910563-B1 | INTEGRIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-05-02 | — | — | EP | disclosed |
| US-6008213-A | A INHIBITOR OF VITRONECTIN RECEPTOR AND FIBRINOGEN RECEPTOR; USEFUL FOR INHIBITING PLATELET AGGREGATION AND OSTEOPOROSIS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-12-28 | — | — | US | disclosed |
| EP-0910563-A1 | INTEGRIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-04-28 | — | — | EP | disclosed |
| EP-0910563-A4 | — | — | 1999-04-28 | — | — | EP | disclosed |
| WO-1997001540-A1 | INTEGRIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-01-16 | — | — | WO | disclosed |